clarivate.com

Articles

Five Medtech Trends to Watch in 2025 | Clarivate

1 month ago | clarivate.com | Annette Boyle

Critical trends for the medtech industry in 2025, including how regulators are addressing AI/machine learning, geographic expansion and supply chain risk mitigation, product portfolio rebalancing, digital technologies enabling outpatient care and green shoots in the financing landscape.
Introducing ProQuest Digital Collections, a new library subscription offering unparalleled breadth, value and access | Clarivate

2 months ago | clarivate.com | Susan Bokern

New offering for academic libraries spans six centuries of essential content to serve researchers and students of all levels
BioWorld by Clarivate Releases Comprehensive 2024 Year in Review

Jan 21, 2025 | clarivate.com | Marian Chu

Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the YearLondon, UK, January 16, 2025 – BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has released its highly anticipated 2024 Year in Review series.
How to unlock the value in your intellectual property portfolio

Nov 18, 2024 | clarivate.com | Alex Schabel

Unlock the value of your IP portfolio with expert guidance on data management, valuation strategies and practical steps to get started.
Medtech Trends to Watch in 2024 | Clarivate

Nov 1, 2024 | clarivate.com

Medtech companies must navigate a raft of external variables to deliver innovation to patients, and the industry is still in a tenuous recovery after a challenging period of unpredictability and uncertainty.
Intellectual Property Solutions - IP Solutions | Clarivate

Nov 1, 2024 | clarivate.com

Create, manage and protect your intellectual property with a range of IP solutions that can help transform your organization. Read more.
Medtech360 MedTech Insights | Clarivate

Nov 1, 2024 | clarivate.com

Identify opportunities for growth within the medical device landscape with comprehensive and actionable MedTech insights from MedTech360. Learn more.
Increasing your likelihood of success in dealmaking discussions

Oct 17, 2024 | clarivate.com | Mike Ward |Sonia Lopez

In-licensing and acquisitions are fast tracks for pharmaceutical companies to access groundbreaking technologies and assets that will drive the next generation of transformative patient treatments. Dealmaking is not a trivial process. Audience members during the recent Clarivate webinar Emerging Deal Trends in Biotech and Pharma identified three of the biggest challenges they face when securing deals.
How the U.S. election could impact the healthcare industries | Clarivate

Oct 17, 2024 | clarivate.com

Healthcare delivery has not been the hottest topic on the campaign trail this election season, despite sharp policy differences between the candidates and
Biotech financing’s rebound: How high will it go?

Sep 17, 2024 | clarivate.com | Mike Ward |Varun Saxena

The biotech industry has experienced a rollercoaster of financing and dealmaking trends over the past few years. From the record-breaking heights of the COVID-19 era to the recent slowdown in 2023, signs of resilience and recovery are beginning to emerge. In the first half of 2024, the biotech industry is witnessing early signs of a rebound in financing and dealmaking activities. However, it may not reach the peak levels seen during the height of the pandemic.